<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wong VW</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><pagination>401-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3378643</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(4)</volume><pubmed_abstract>Maintenance of adult tissues is carried out by stem cells and is sustained throughout life in a highly ordered manner. Homeostasis within the stem-cell compartment is governed by positive- and negative-feedback regulation of instructive extrinsic and intrinsic signals. ErbB signalling is a prerequisite for maintenance of the intestinal epithelium following injury and tumour formation. As ErbB-family ligands and receptors are highly expressed within the stem-cell niche, we hypothesize that strong endogenous regulators must control the pathway in the stem-cell compartment. Here we show that Lrig1, a negative-feedback regulator of the ErbB receptor family, is highly expressed by intestinal stem cells and controls the size of the intestinal stem-cell niche by regulating the amplitude of growth-factor signalling. Intestinal stem-cell maintenance has so far been attributed to a combination of Wnt and Notch activation and Bmpr inhibition. Our findings reveal ErbB activation as a strong inductive signal for stem-cell proliferation. This has implications for our understanding of ErbB signalling in tissue development and maintenance and the progression of malignant disease.</pubmed_abstract><journal>Nature cell biology</journal><pubmed_title>Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling.</pubmed_title><pmcid>PMC3378643</pmcid><funding_grant_id>17044</funding_grant_id><funding_grant_id>G0800784B</funding_grant_id><funding_grant_id>088454</funding_grant_id><funding_grant_id>979886</funding_grant_id><funding_grant_id>G0800784</funding_grant_id><funding_grant_id>079249</funding_grant_id><pubmed_authors>Wabik A</pubmed_authors><pubmed_authors>Watt FM</pubmed_authors><pubmed_authors>Winton DJ</pubmed_authors><pubmed_authors>Jensen KB</pubmed_authors><pubmed_authors>Itami S</pubmed_authors><pubmed_authors>Wright NA</pubmed_authors><pubmed_authors>Clevers H</pubmed_authors><pubmed_authors>Buczacki S</pubmed_authors><pubmed_authors>Trotter MW</pubmed_authors><pubmed_authors>Wong VW</pubmed_authors><pubmed_authors>Stange DE</pubmed_authors><pubmed_authors>Page ME</pubmed_authors><pubmed_authors>van de Wetering M</pubmed_authors><pubmed_authors>Poulsom R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling.</name><description>Maintenance of adult tissues is carried out by stem cells and is sustained throughout life in a highly ordered manner. Homeostasis within the stem-cell compartment is governed by positive- and negative-feedback regulation of instructive extrinsic and intrinsic signals. ErbB signalling is a prerequisite for maintenance of the intestinal epithelium following injury and tumour formation. As ErbB-family ligands and receptors are highly expressed within the stem-cell niche, we hypothesize that strong endogenous regulators must control the pathway in the stem-cell compartment. Here we show that Lrig1, a negative-feedback regulator of the ErbB receptor family, is highly expressed by intestinal stem cells and controls the size of the intestinal stem-cell niche by regulating the amplitude of growth-factor signalling. Intestinal stem-cell maintenance has so far been attributed to a combination of Wnt and Notch activation and Bmpr inhibition. Our findings reveal ErbB activation as a strong inductive signal for stem-cell proliferation. This has implications for our understanding of ErbB signalling in tissue development and maintenance and the progression of malignant disease.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Mar</publication><modification>2021-02-20T04:19:07Z</modification><creation>2019-03-27T00:54:45Z</creation></dates><accession>S-EPMC3378643</accession><cross_references><pubmed>22388892</pubmed><doi>10.1038/ncb2464</doi></cross_references></HashMap>